Paper412648
Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
Anderson ET and 2 others. Chemotherapy, 1978. Cited by 180 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Papers, record 412648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/412648
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Sepsis | Major topic |
| Aminoglycosides | |
| Ampicillin | |
| Carbenicillin | |
| Cephalosporins | |
| Drug Evaluation | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Escherichia coli | |
| Humans | |
| Klebsiella pneumoniae | |
| Microbial Sensitivity Tests | |
| Proteus | |
| Pseudomonas aeruginosa | |
| Serratia marcescens |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,148,672 | Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/41148672 | PubMed |
| 33,027,987 | The Antibacterial and Anti-biofilm Activity of Metal Complexes Incorporating 3,6,9-Trioxaundecanedioate and 1,10-Phenanthroline Ligands in Clinical Isolates of Pseudomonas Aeruginosa from Irish Cystic Fibrosis Patients. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/33027987 | PubMed |
| 31,057,792 | A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections. | Antimicrob Resist Infect Control | 2019 | https://conductscience.org/library/papers/31057792 | PubMed |
| 30,904,374 | Antipseudomonal monotherapy or combination therapy for older adults with community-onset pneumonia and multidrug-resistant risk factors: a retrospective cohort study. | Am J Infect Control | 2019 | https://conductscience.org/library/papers/30904374 | PubMed |
| 29,456,647 | Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29456647 | PubMed |
| 26,031,965 | Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. | Curr Infect Dis Rep | 2015 | https://conductscience.org/library/papers/26031965 | PubMed |
| 24,955,088 | In vitro antibacterial effect of wasp (Vespa orientalis) venom. | J Venom Anim Toxins Incl Trop Dis | 2014 | https://conductscience.org/library/papers/24955088 | PubMed |
| 24,655,422 | Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/24655422 | PubMed |
| 24,184,742 | An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. | Virulence | 2014 | https://conductscience.org/library/papers/24184742 | PubMed |
| 23,593,006 | The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/23593006 | PubMed |
| 23,157,735 | Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia. | BMC Infect Dis | 2012 | https://conductscience.org/library/papers/23157735 | PubMed |
| 22,763,634 | Combination therapy for treatment of infections with gram-negative bacteria. | Clin Microbiol Rev | 2012 | https://conductscience.org/library/papers/22763634 | PubMed |
| 19,164,144 | Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19164144 | PubMed |
| 8,843,303 | Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8843303 | PubMed |
| 8,457,980 | Gram-negative sepsis: a dilemma of modern medicine. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8457980 | PubMed |
| 7,399,713 | Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis. | Infection | 1980 | https://conductscience.org/library/papers/7399713 | PubMed |
| 7,379,929 | Antimicrobial chemotherapy - a clinician's viewpoint. | Experientia | 1980 | https://conductscience.org/library/papers/7379929 | PubMed |
| 6,792,982 | Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6792982 | PubMed |
| 6,775,591 | Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6775591 | PubMed |
| 6,538,773 | In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6538773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/412648
GET https://conductscience.org/api/papers/v1/412648/cited_by?page=2